About this journal
Aims and scope
Vascular Health and Risk Management is an international, peer-reviewed open access journal focusing on the maintenance of vascular health, disease prevention, risk factors, therapeutics, monitoring and risk management of vascular disease and its sequelae. The journal also seeks to address the association between lifestyle, hypertension, vascular biology, metabolic syndrome, obesity, aging, and vascular health & disease. The journal considers studies on drugs, drug design and development, and therapeutic use.
Specific topics covered by the journal include:
- Assessment of cardiovascular risk factors
- Management and monitoring of cardiovascular risk factors
- Methods for arterial evaluation and risk factors
The journal welcomes original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary.
Vascular Health and Risk Management will no longer consider meta-analyses for publication.
Journal metrics
Usage
- 166K annual downloads/views
Citation metrics
- 2.6 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 3.3 (2023) 5 year IF
- 4.2 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.981 (2023) SNIP
- 0.647 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief:
Prof. Dr. Roland Asmar, Medical Research, Foundation-Medical Research Institutes (F-MRI) ®, Geneva, Switzerland
Associate Editors-in-Chief:
Dr Akash Batta, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, India
Professor Mirna N Chahine, Basic Sciences Department. Foundation-Medical Research Institutes (F-MRI®), Beirut, Lebanon / Genev, Lebanese University. Faculty of Medical sciences, Lebanon
Dr Daniel Duprez, Cardiovascular Division, University of Minnesota, United States
Prof. Dr. Pietro Scicchitano, Cardiology, University of Bari, Italy
Dr Harry Struijker-Boudier, Pharmacology, Maastricht University, Netherlands
Dr Konstantinos Tziomalos, Department of Internal Medicine, Aristotle University of Thessaloniki, Greece
Editorial Board:
Dr Amod Amritphale, FACC, FSCAI, Interventional Cardiologist, Mercy Hospitals and Clinics, Springfield MO USA
Dr Christina Antza, 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University, Greece
Dr Pitchai Balakumar, Pharmacology Unit, Faculty of Pharmacy, AIMST University, Malaysia
Professor Christie Ballantyne, Department of Atherosclerosis and Vascular Medicine, Baylor College of Medicine, United States
Professor Maciej Banach, Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Poland; Head, Cardiovascular Research Centre, Universit of Zielona Gora, Poland; Consultant Professor, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Reseach Institute (PMMHRI), Lodz, Poland; Secretary of the European Atherosclerosis Society (EAS), and President of the International Lipid Expert Panel (ILEP)
Dr Ravinay Bhindi, Department of Cardiology, University of Sydney Royal North Shore Hospital, Australia
Professor Eric Bruckert, Service d'endocrinologie-métabolisme, Paris, France
Dr Patrick Brunel, Cardiology, University René Descartes, Paris, France.
Prof. Dr. Peter de Leeuw, Department of Medicine, University Hospital Maastricht, Netherlands
Prof. Dr. Francesco Fantin, Medicine, University of Verona, Italy
Prof. Dr. Jan Filipovsky, Internal Medicine, Charles University, Pilsen, Czech Republic
Dr Luis Garcia-Ortiz, Primary Care Research Unit of Salamanca(APISAL), Biomedical Research Institute of Salamanca (IBSAL), Spain
Prof. Dr. Armen Yuri Gasparyan, Clinical Research Unit, Dudley Group of Hospitals NHS Trust, West Midlands, United Kingdom
Professor Joseph Izzo, Medicine and Pharmacology, State University of New York, United States
Prof. Dr. Bojan Jelaković, Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Croatia
Prof. Dr. Amudha Kadirvelu, School of Medicine and Health Sciences, Monash University Malaysia, Malaysia
Professor Gregory Y H Lip, Liverpool Centre for Cardiovascular Science, University of Liverpool, UK; National Institute for Health Research (NIHR) Senior Investigator; Distinguished Professor, Faculty of Medicine, Aalborg University, Denmark; Adjunct Professor, Yonsei University, Seoul, South Korea; Adjunct Professor, Seoul National University, Seoul, South Korea
Professor Iveta Mintale, Latvian Centre of Cardiology, Pauls Stradiņ Clinical University Hospital; and Research Institute of Cardiology, University of Latvia, Riga, Latvia
Prof. Dr. Salvador Moncada, Cancer Domain, University of Manchester, United Kingdom
Dr Vasilios Papademetriou, Center for Hypertension, Kidney & Vascular Research, VA Medical Center, Georgetown University Medical Center, Washington, DC, United States
Prof. Dr. Ibrahim Sari, Department of Cardiology, School of Medicine, Marmara University, Istanbul, Turkey
Dr Rahul Sheth, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Dr Kohji Shirai, Emeritus Professor of Medical School, Toho University, Japan
Prof. Dr. Yuriy M Sirenko, Head of Secondary and Pulmonary Hypertension Department in the NSC MD Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of the National Academy of the Medical Science of Ukraine
Professor Reza Tabrizchi, Pharmacology (Cardiovascular), Memorial University of Newfoundland, Canada
Prof. Dr. Nebojsa Tasic, Cardiovascular Research Centre, Cardiovascular Institute Dedinje, Belgrade, Serbia
Dr Larry Weinrauch, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States
Professor Nanette Wenger, Department of Medicine, Emory University School of Medicine, United States
Prof. Dr. Parounak Zelveian, Preventive Cardiology Department, Institute of Cardiology named after Levon Hovhannisyan, Yerevan, Armenia
Professor Chunyu Zeng, Cardiology, The Third Military Medical University, China Mainland (PRC)
Dr Yi Zhang, Department of Cardiology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, China Mainland (PRC)
Abstracting and indexing
Vascular Health and Risk Management is indexed/tracked/covered by the following services:
ICAAP
Index Copernicus
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Medline (NLM)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Vascular Health and Risk Management is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
Continuous
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors